Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus Infections.
- DOI
- 10.3390/v13020312
- Published
- 2021 Feb 17
- Container
- Viruses
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/v13020312,
title = {Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus Infections.},
author = {Flude BM and Nannetti G and Mitchell P and Compton N and Richards C and Heurich M and Brancale A and Ferla S and Bassetto M},
year = {2021},
journal = {Viruses},
doi = {10.3390/v13020312},
url = {https://doi.org/10.3390/v13020312}
}RIS
TY - JOUR TI - Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus Infections. AU - Flude BM AU - Nannetti G AU - Mitchell P AU - Compton N AU - Richards C AU - Heurich M AU - Brancale A AU - Ferla S AU - Bassetto M PY - 2021 JO - Viruses DO - 10.3390/v13020312 UR - https://doi.org/10.3390/v13020312 ER -
APA
BM, F., G, N., P, M., N, C., C, R., M, H., A, B., S, F., & M, B. (2021). Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus Infections.. Viruses. https://doi.org/10.3390/v13020312
Source records
- pubmed · retrieved 2026-09-25T20:17:06.093Z